Breaks Categories: News

WednesdayOct 14, 2026 9:30 am

NetworkNewsBreaks – InvestorNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Natural Hydrogen Exploration and Growth Initiatives Spotlighted in ADVFN UK Article

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N), is the subject of an ADVFN UK feature by Fiona Craig examining the company's efforts to establish a commercial pathway for natural hydrogen production in Saskatchewan. The article focuses on MAX Power's flagship Lawson discovery, where drilling and three-dimensional seismic surveys have identified a potentially significant subsurface hydrogen system. With completions testing scheduled for the second half of October 2026, the company is seeking to establish key reservoir characteristics and assess production feasibility. Craig also…

Continue Reading

WednesdayOct 14, 2026 9:10 am

NetworkNewsBreaks – Globavend Holdings Limited (NASDAQ: GVH) to Present at 2026 ThinkEquity Conference on Oct. 15

Globavend Holdings (NASDAQ: GVH), an emerging e-commerce logistics provider and AI-powered digital entertainment company, announced that Chairman Kenny K.M. Fung will present at the 2026 ThinkEquity Conference on Thursday, Oct. 15, 2026, at 3:30 p.m. ET at the Mandarin Oriental Hotel in New York City. Fung will provide an overview of the company’s business, recent developments and growth strategy, highlighting its established cross-border logistics operations and expansion into digital and live entertainment through Loomi Entertainment Group Limited. The presentation will cover growth opportunities in Australia and New Zealand’s e-commerce markets, Globavend’s proprietary AI-powered cinematic production platform, Imaginary, its Loomi: Short…

Continue Reading

WednesdayOct 14, 2026 9:00 am

NetworkNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Leadership Changes and Natural Hydrogen Commercialization Strategy Highlighted in HotCopper Feature by Jerry Collova

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N), a natural hydrogen exploration company, is advancing toward a critical phase of technical evaluation and potential commercialization at its Lawson discovery in Saskatchewan, according to a recent HotCopper article by Jerry Collova. The company has appointed former Saskatchewan cabinet minister Rob Norris as CEO as it prepares to begin completions testing at its Lawson and Bracken discoveries in the second half of October 2026. MAX Power has also strengthened its technical leadership with the appointments…

Continue Reading

TuesdayOct 13, 2026 1:12 pm

NetworkNewsBreaks – SS Innovations International, Inc. (NASDAQ: SSII) Submits FDA Response for SSi Mantra Surgical Robotic System 

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced that it submitted its response to a request for additional information from the U.S. Food and Drug Administration (FDA) on Oct. 5, 2026, regarding its 510(k) submission for the SSi Mantra surgical robotic system. The response includes final data from an expanded human clinical and human factors validation study, as well as a bridging study completed in August 2026 at Hospital Internacional de Colombia, a member of the Mayo Clinic Care Network. The submission covers the initial indication of cholecystectomy, or gallbladder removal. The company anticipates that the…

Continue Reading

TuesdayOct 13, 2026 11:48 am

NetworkNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Featured in AINewsWire Editorial Highlighting Power-Backed AI Infrastructure 

AZIO AI Holdings (NASDAQ: AZIO) announced its placement in an editorial published by AINewsWire (AINW), one of more than 75 brands within the Dynamic Brand Portfolio at InvestorBrandNetwork (IBN). The editorial, titled "Contracted Capacity Becomes Key Metric for AI Infrastructure Investors to Watch," examines how rising electricity demand from artificial intelligence (AI) data centers is reshaping infrastructure development and increasing the importance of securing reliable power capacity. The article highlights AZIO AI's Atlas One project in south Texas, where the company recently signed its first hosting agreement with Power Champion Investment Limited for an initial 10 megawatts of capacity, with…

Continue Reading

TuesdayOct 13, 2026 11:24 am

NetworkNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Appoints Rob Norris CEO, Expands Leadership Team and Launches IBN Investor Awareness Campaign 

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.  MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announced the appointment of former Saskatchewan cabinet minister and company director Rob Norris as CEO, effective immediately, as it advances its natural hydrogen commercialization strategy, U.S. capital markets expansion and strategic partnerships. Former CEO Ran Narayanasamy transitions to managing director of innovation and international strategy, while Tom Kishchuk has been named chief technology officer and Brendan Bishop chief geochemist. The leadership changes come as MAX Power prepares to begin completions testing at its Lawson and…

Continue Reading

TuesdayOct 13, 2026 10:50 am

NetworkNewsBreaks – NanoViricides (NYSE American: NNVC) Reports Progress in Phase IIA Ebola Treatment Trial of NV-387 Oral Gummies

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage antiviral drug developer, reported progress in its Phase IIA clinical trial evaluating NV-387 Oral Gummies for the treatment of Ebola Bundibugyo virus infection in the Democratic Republic of Congo. The exploratory trial, designed to enroll up to 20 patients with varying disease severity, is assessing the safety and tolerability of treatment regimens ranging from six to 12 days. Although the study is not designed to establish statistically significant efficacy, the company said it may identify preliminary signs of antiviral activity. Following completion of the trial and evaluation of the results, NanoViricides plans to…

Continue Reading

TuesdayOct 13, 2026 10:20 am

NetworkNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Announces MindWave NILA Token Listing on Pionex Exchange

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that NILA, the native utility and governance token of the MindChain network developed by its wholly owned subsidiary, MindWave Innovations Inc. USA, is scheduled to begin trading on the Pionex cryptocurrency exchange Oct. 14, 2026, at 6 a.m. Eastern time. The listing will make NILA available to eligible users through the NILA/USDT trading pair, with access to Pionex's standard trading features and automated trading tools. The listing expands international access to NILA ahead of its planned migration to MindChain, an Ethereum-based Layer 2 network designed to support enterprise blockchain applications. MindWave has…

Continue Reading

TuesdayOct 13, 2026 9:20 am

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Sponsors Ukrainian Defense Tech Pavilion Reception at AUSA 2026

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0), a defense technology company delivering positioning in GPS-denied environments, announced its sponsorship of the Ukrainian Defense Tech Pavilion Reception at the Association of the United States Army (AUSA) 2026 Annual Meeting & Exposition, taking place Oct. 12-14 in Washington, D.C. The company's U.S. leadership team will attend the exposition to meet with military officials, allied partners and defense industry stakeholders regarding its Overwatch Positioning Network, which provides positioning and targeting capabilities for uncrewed systems operating without…

Continue Reading

TuesdayOct 13, 2026 9:10 am

NetworkNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at World ADC Congress

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, presented its first in vivo proof-of-concept data and additional in vitro findings validating its BiTAC-ADC technology platform at the 17th World ADC Congress in San Diego. The in vivo study demonstrated significant tumor regression in a breast cancer model following a single 3 mg/kg dose, with no observed decrease in body weight. The results also showed that both BiTAC-ADC components were required to produce the intended tumor-specific response. Additional in vitro studies demonstrated the platform's ability to distinguish cancer cells from healthy cells, prevent the release of active…

Continue Reading